Skip to main content

Abstract

An “individual with a disability” has a physical impairment or record of such an impairment that substantially limits a “major life activity.” Today, “person with a disability” is a more widely used term than “handicapped” as this phrasing reflects a positive approach by putting people first, not the disability. The disability term is used to refer an individual functioning including motor, sensory, cognitive, intellectual impairment, mental illness, and various types of chronic diseases (Oliver 1995; Crow 2008).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Al-Araji AH, Oger J (2005) Reappraisal of Lhermitte’s sign in multiple sclerosis. Mult Scler J 11(4):398–402

    Article  Google Scholar 

  • Bax M et al (2005) Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol 47(8):571–576

    Article  PubMed  Google Scholar 

  • Betarbet R et al (2000) Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci 3(12):1301

    Article  CAS  PubMed  Google Scholar 

  • Bhattacharyya KB (2016) The story of George Huntington and his disease. Ann Indian Acad Neurol 19(1):25

    Article  PubMed  PubMed Central  Google Scholar 

  • Bitsch A et al (2000) Acute axonal injury in multiple sclerosis: correlation with demyelination and inflammation. Brain 123(6):1174–1183

    Article  PubMed  Google Scholar 

  • Chandra V et al (2006) Neurological disorders. In: Disease control priorities. World Bank, Washington, DC, p 21

    Google Scholar 

  • Cho HJ et al (2012) MicroRNA-205 regulates the expression of Parkinson’s disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet 22(3):608–620

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Clifford DB, Trotter JL (1984) Pain in multiple sclerosis. Arch Neurol 41(12):1270–1272

    Article  CAS  PubMed  Google Scholar 

  • Corti O, Lesage S, Brice A (2011) What genetics tells us about the causes and mechanisms of Parkinson’s disease. Physiol Rev 91(4):1161–1218

    Article  CAS  PubMed  Google Scholar 

  • Crow KL (2008) Four types of disabilities: their impact on online learning. TechTrends 52(1):51–55

    Article  Google Scholar 

  • Ebers GC (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7(3):268–277

    Article  PubMed  Google Scholar 

  • Focke NK et al (2011) Differentiation of typical and atypical Parkinson syndromes by quantitative MR imaging. Am J Neuroradiol 32(11):2087–2092

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Folstein SE, Brandt J, Folstein MF (1990) Huntington’s disease. Oxford University Press, New York

    Google Scholar 

  • Freeman JM, Nelson KB (1988) Intrapartum asphyxia and cerebral palsy. Pediatrics 82(2):240–249

    CAS  PubMed  Google Scholar 

  • Frohman EM, Racke MK, Raine CS (2006) Multiple sclerosis—the plaque and its pathogenesis. N Engl J Med 354(9):942–955

    Article  CAS  PubMed  Google Scholar 

  • Geurts JJ, Barkhof F (2008) Grey matter pathology in multiple sclerosis. Lancet Neurol 7(9):841–851

    Article  PubMed  Google Scholar 

  • Goetz CG (2011) The history of Parkinson’s disease: early clinical descriptions and neurological therapies. Cold Spring Harb Perspect Med 1(1):a008862

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Goodin DS et al (2002) Disease modifying therapies in multiple sclerosis. Neurology 58(2):169–178

    Article  CAS  PubMed  Google Scholar 

  • Guehl D et al (1999) Trichloroethylene and parkinsonism: a human and experimental observation. Eur J Neurol 6(5):609–611

    Article  CAS  PubMed  Google Scholar 

  • Hannan AJ (2004) Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington’s disease. Acta Biochim Pol Engl Ed 51:415–430

    CAS  Google Scholar 

  • Indaco A et al (1994) Chronic and acute pain syndromes in patients with multiple sclerosis. Acta Neurol 16(3):97

    CAS  Google Scholar 

  • Jankovic J (2008) Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79(4):368–376

    Article  CAS  PubMed  Google Scholar 

  • Jimenez-Sanchez M et al (2016) Huntington’s disease: mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harb Perspect Med 7:a024240

    Article  CAS  Google Scholar 

  • Johnston MV, Hagberg H (2007) Sex and the pathogenesis of cerebral palsy. Dev Med Child Neurol 49(1):74–78

    Article  PubMed  Google Scholar 

  • Jones MW et al (2007) Cerebral palsy: introduction and diagnosis (part I). J Pediatr Health Care 21(3):146–152

    Article  PubMed  Google Scholar 

  • Kala SV, Jadhav AL (1995) Region-specific alterations in dopamine and serotonin metabolism in brains of rats exposed to low levels of lead. Neurotoxicology 16(2):297–308

    CAS  PubMed  Google Scholar 

  • Li S-H, Li X-J (2004) Huntingtin–protein interactions and the pathogenesis of Huntington’s disease. Trends Genet 20(3):146–154

    Article  CAS  PubMed  Google Scholar 

  • Lim SY, Lang AE (2010) The nonmotor symptoms of Parkinson’s disease—an overview. Mov Disord 25(S1):S123–S130

    Article  PubMed  Google Scholar 

  • Louis ED, Frucht SJ (2007) Prevalence of essential tremor in patients with Parkinson’s disease vs. Parkinson-plus syndromes. Mov Disord 22(10):1402–1407

    Article  PubMed  Google Scholar 

  • Love S, Coakham HB (2001) Trigeminal neuralgia: pathology and pathogenesis. Brain 124(12):2347–2360

    Article  CAS  PubMed  Google Scholar 

  • Marchand S (2008) The physiology of pain mechanisms: from the periphery to the brain. Rheum Dis Clin N Am 34(2):285–309

    Article  Google Scholar 

  • McPhee SJ, Hammer GD (1995) Pathophysiology of disease: an introduction to clinical medicine. Lange Medical Books, New York

    Google Scholar 

  • Merskey H (1991) The definition of pain. Eur Psychiatry 6(4):153–159

    Google Scholar 

  • Milo R, Kahana E (2010) Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 9(5):A387–A394

    Article  CAS  PubMed  Google Scholar 

  • Minear W (1956) A classification of cerebral palsy. Pediatrics 18(5):841–852

    CAS  PubMed  Google Scholar 

  • Mo C, Hannan AJ, Renoir T (2015) Environmental factors as modulators of neurodegeneration: insights from gene–environment interactions in Huntington’s disease. Neurosci Biobehav Rev 52:178–192

    Article  PubMed  Google Scholar 

  • Mohan H (2005) Textbook of pathology. Jaypee Brothers Medical Publishers, New Delhi.

    Book  Google Scholar 

  • Moulin DE, Foley KM, Ebers GC (1988) Pain syndromes in multiple sclerosis. Neurology 38(12):1830–1830

    Article  CAS  PubMed  Google Scholar 

  • Navarro-Yepes J et al (2014) Antioxidant gene therapy against neuronal cell death. Pharmacol Ther 142(2):206–230

    Article  CAS  PubMed  Google Scholar 

  • Nelson KB, Willoughby RE (2000) Infection, inflammation and the risk of cerebral palsy. Curr Opin Neurol 13(2):133–139

    Article  CAS  PubMed  Google Scholar 

  • O’connor AB et al (2008) Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 137(1):96–111

    Article  PubMed  Google Scholar 

  • Oliver M (1995) Understanding disability: from theory to practice. Macmillan International Higher Education, Basingstoke

    Google Scholar 

  • Orrell RW (2005) Multiple sclerosis: the history of a disease. Demos Medical Publishing, New York

    Google Scholar 

  • Pahwa R, Lyons KE (2013) Handbook of Parkinson’s disease. CRC Press, Boca Raton

    Book  Google Scholar 

  • Panteliadis C, Panteliadis P, Vassilyadi F (2013) Hallmarks in the history of cerebral palsy: from antiquity to mid-20th century. Brain and Development 35(4):285–292

    Article  PubMed  Google Scholar 

  • Pavlou MAS, Outeiro TF (2017) Epigenetics in Parkinson’s disease. In: Neuroepigenomics in aging and disease. Springer, Cham, pp 363–390

    Chapter  Google Scholar 

  • Perlman JM (1997) Intrapartum hypoxic-ischemic cerebral injury and subsequent cerebral palsy: medicolegal issues. Pediatrics 99(6):851–859

    Article  CAS  PubMed  Google Scholar 

  • Popescu BFG, Pirko I, Lucchinetti CF (2013) Pathology of multiple sclerosis: where do we stand? Continuum Lifelong Learn Neurol 19(4 Multiple Sclerosis):901

    Article  Google Scholar 

  • Purkerson-Parker S, McDaniel KL, Moser VC (2001) Dopamine transporter binding in the rat striatum is increased by gestational, perinatal, and adolescent exposure to heptachlor. Toxicol Sci 64(2):216–223

    Article  CAS  PubMed  Google Scholar 

  • Rappold PM et al (2011) Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3. Proc Natl Acad Sci 108(51):20766–20771

    Article  PubMed  PubMed Central  Google Scholar 

  • Raymond LA et al (2011) Pathophysiology of Huntington’s disease: time-dependent alterations in synaptic and receptor function. Neuroscience 198:252–273

    Article  CAS  PubMed  Google Scholar 

  • Reddihough DS, Collins KJ (2003) The epidemiology and causes of cerebral palsy. Aust J Physiother 49(1):7–12

    Article  PubMed  Google Scholar 

  • Reid S et al (2006) Factor V Leiden mutation: a contributory factor for cerebral palsy? Dev Med Child Neurol 48(1):14–19

    Article  PubMed  Google Scholar 

  • Reiner A et al (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci 85(15):5733–5737

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rosenbaum P et al (2007) A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 109(Suppl 109):8–14

    PubMed  Google Scholar 

  • Sankar C, Mundkur N (2005) Cerebral palsy-definition, classification, etiology and early diagnosis. Indian J Pediatr 72(10):865–868

    Article  PubMed  Google Scholar 

  • Smith KJ, McDonald W (1999) The pathophysiology of multiple sclerosis⋮ the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond Ser B Biol Sci 354(1390):1649–1673

    Article  CAS  Google Scholar 

  • Solaro C, Trabucco E, Uccelli MM (2013) Pain and multiple sclerosis: pathophysiology and treatment. Curr Neurol Neurosci Rep 13(1):320

    Article  CAS  PubMed  Google Scholar 

  • Steffan JS et al (2004) SUMO modification of huntingtin and Huntington’s disease pathology. Science 304(5667):100–104

    Article  CAS  PubMed  Google Scholar 

  • Steiner I, Nisipianu P, Wirguin I (2001) Infection and the etiology and pathogenesis of multiple sclerosis. Curr Neurol Neurosci Rep 1(3):271–276

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Torfs CP et al (1990) Prenatal and perinatal factors in the etiology of cerebral palsy. J Pediatr 116(4):615–619

    Article  CAS  PubMed  Google Scholar 

  • Tselis A (2011) Evidence for viral etiology of multiple sclerosis. In: Seminars in neurology. Thieme Medical Publishers, Inc., New York

    Google Scholar 

  • Vale TC, Cardoso F (2015) Chorea: a journey through history. Tremor Other Hyperkinet Mov 5:pii: tre-5-296

    Google Scholar 

  • van Dellen A, Hannan AJ (2004) Genetic and environmental factors in the pathogenesis of Huntington’s disease. Neurogenetics 5(1):9–17

    Article  CAS  PubMed  Google Scholar 

  • Verina T et al (2011) Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. Neurotoxicology 32(2):215–226

    Article  CAS  PubMed  Google Scholar 

  • Vonsattel J-P et al (1985) Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 44(6):559–577

    Article  CAS  PubMed  Google Scholar 

  • Wacker M, Holick MF (2013) Sunlight and vitamin D: a global perspective for health. Derm Endocrinol 5(1):51–108

    Article  CAS  Google Scholar 

  • Wagner SR, Greene FE (1978) Dieldrin-induced alterations in biogenic amine content of rat brain. Toxicol Appl Pharmacol 43(1):45–55

    Article  CAS  PubMed  Google Scholar 

  • Walker FO (2007) Huntington’s disease. Lancet 369(9557):218–228

    Article  CAS  PubMed  Google Scholar 

  • Watson RR, Killgore WD (2016) Nutrition and lifestyle in neurological autoimmune diseases: multiple sclerosis. Academic, Amsterdam

    Google Scholar 

  • Wexler NS (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset. Proc Natl Acad Sci 101(10):3498–3503

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wexler NS et al (1987) Homozygotes for Huntington’s disease. Nature 326(6109):194–197

    Article  CAS  PubMed  Google Scholar 

  • Wingerchuk DM, Carter JL (2014) Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. Mayo Clin Proc 89(2):225–240. Elsevier

    Article  PubMed  Google Scholar 

  • World Health Organization (1980) International classification of impairments, disabilities, and handicaps: a manual of classification relating to the consequences of disease, published in accordance with resolution WHA29. 35 of the Twenty-ninth World Health Assembly, May 1976

    Google Scholar 

  • Xiao W et al (2011) A genomic storm in critically injured humans. J Exp Med 208(13):2581–2590

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yoon BH et al (1997) Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 177(1):19–26

    Article  CAS  PubMed  Google Scholar 

  • Zecca L et al (2002) The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson’s disease. FEBS Lett 510(3):216–220

    Article  CAS  PubMed  Google Scholar 

  • Zheng W, Monnot AD (2012) Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases. Pharmacol Ther 133(2):177–188

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Rai, S.N. et al. (2019). Pathophysiology of the Disease Causing Physical Disability. In: Paul, S. (eds) Biomedical Engineering and its Applications in Healthcare. Springer, Singapore. https://doi.org/10.1007/978-981-13-3705-5_23

Download citation

Publish with us

Policies and ethics